Innovation in Drug Development with Jeff Geschwind, MD Jeff Geschwind, MD, founded Cage Pharma, focusing on novel cancer drugs that target tumor metabolism. His research offers new hope for treating resistant cancers through glycolytic inhibition. https://www.linkedin.com/in/jeff-geschwind-037200174